Skip to content

Thursday, June 25, 2026

Latest:

Sitting at your desk all day? Get up and get moving!
FROM THE LABS: Dr. Kara Marshall has been awarded the 2026 McKnight Endowment Fund
Natural vs. artificial sweetener: Which is best for you?
Navigating menopause with care, clarity and evidence
Wastewater analysis offers a new way to monitor HIV in communities

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

ACTL6A

A new mechanism of cisplatin resistance in cancer, and how to reverse it

April 22, 2021 ACTL6A, cancer resistance to therapy, cisplatin, DNA repair, epigenetic chromatin remodeling, panobinostat, Research

ACLT6A overexpression confers cancer cells resistance to cisplatin, and researchers found a way to reverse it.

From the Labs: Image of the Month

From the Labs: Tau travels between neurons

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951